KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS

Clinical trials for KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS explained in plain language.

Never miss a new study

Get alerted when new KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS trials appear

Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 1 Terminated 1

New drug may help 'Hard-to-Transplant' kidney patients stay healthy for years

Disease control Ongoing

This study follows 64 highly sensitized kidney transplant patients who previously received either the drug imlifidase or standard care to enable transplantation. Researchers will track how many patients are alive and free of dialysis at 3 and 5 years. The goal is to see if imlifi…

Matched conditions: KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS

Sponsor: Hansa Biopharma AB • Aim: Disease control

Last updated Jun 23, 2026 11:55 UTC

KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS

Get alerted when new KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS trials appear

New drug may help 'Hard-to-Transplant' kidney patients stay healthy for years